Bristol-Myers Squibb

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. 

CEO
Christopher S. Boerner
CEOChristopher S. Boerner
Employees
32,500
Employees32,500
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
1933
Founded1933
Employees
32,500
Employees32,500

BMY Key Statistics

Market cap
118.83B
Market cap118.83B
Price-Earnings ratio
17.00
Price-Earnings ratio17.00
Dividend yield
4.13%
Dividend yield4.13%
Average volume
10.04M
Average volume10.04M
High today
$60.73
High today$60.73
Low today
$58.00
Low today$58.00
Open price
$59.97
Open price$59.97
Volume
18.37M
Volume18.37M
52 Week high
$62.89
52 Week high$62.89
52 Week low
$42.52
52 Week low$42.52

Stock Snapshot

Bristol-Myers Squibb(BMY) stock is priced at $58.50, giving the company a market capitalization of 118.83B. It carries a P/E multiple of 17.00 and pays a dividend yield of 4.1%.

During the trading session on 2026-05-01, Bristol-Myers Squibb(BMY) shares reached a daily high of $60.73 and a low of $58.00. At a current price of $58.50, the stock is +0.9% higher than the low and still -3.7% under the high.

Trading activity shows a volume of 18.37M, compared to an average daily volume of 10.04M.

The stock's 52-week range extends from a low of $42.52 to a high of $62.89.

The stock's 52-week range extends from a low of $42.52 to a high of $62.89.

BMY News

Benzinga 1d
Why Is Bristol-Myers Squibb Stock Trading Higher On Thursday?

The U.S. large pharma company reported adjusted earnings of $1.58, beating the Wall Street estimate of $1.42. Sales of $11.49 billion increased 3%, surpassing...

Why Is Bristol-Myers Squibb Stock Trading Higher On Thursday?
The Motley Fool 1d
Bristol Myers Q1 2026 Earnings Transcript

Image source: The Motley Fool. April 30, 2026, 8 a.m. ET CALL PARTICIPANTS Board Chair and Chief Executive Officer — Christopher Boerner Chief Financial Office...

Bristol Myers Q1 2026 Earnings Transcript
TipRanks 2d
Bristol Myers Squibb Posts Q1 2026 Results, Reaffirms Outlook

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

Analyst ratings

58%

of 31 ratings
Buy
38.7%
Hold
58.1%
Sell
3.2%

More BMY News

Nasdaq 2d
Bristol-Myers Squibb Reaffirms FY26 Outlook - Update

(RTTNews) - While reporting financial results for the first quarter on Thursday, Bristol-Myers Squibb Co. (BMY) reaffirmed its adjusted earnings and revenue gro...

Bristol-Myers Squibb Reaffirms FY26 Outlook - Update
Simply Wall St 3d
Does Expanded MTAP-CDx Partnership With Foundation Medicine Change The Bull Case For Bristol-Myers Squibb?

Earlier this month, Foundation Medicine announced an expanded collaboration with Bristol-Myers Squibb to develop FoundationOne CDx as a next-generation sequenci...

Does Expanded MTAP-CDx Partnership With Foundation Medicine Change The Bull Case For Bristol-Myers Squibb?

People also own

Based on the portfolios of people who own BMY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.